Oncology
Conference Coverage
I am not fine: The heavy toll cancer takes
“I thought I was as exhausted, and isolated, and neglected as I could get, and then he came home.”
Conference Coverage
Adjuvant nivo+ipilimumab fails in kidney cancer, in contrast to pembro
The results contrast with those seen with pembrolizumab in the same setting.
Opinion
Had my patient come in today, we may have had other options
FDA’s approval of trastuzumab deruxtecan is a game-changer for NSCLC patients with HER alterations.
Opinion
Cancer as a full contact sport
The complexity of cancer care has long necessitated a team approach to planning cancer treatment.
Opinion
In progressive lung cancer second biopsies may be the norm now
Many years after their discovery, we finally have a new string of EGFR-TKI approvals for NSCLC.
From the Journals
Cost paramount when choosing metastatic breast cancer treatment
“Our analysis provides quantifiable evidence to help providers choose lower priced, but equally effective sequences of drugs.”
From the Journals
New guidance on acupuncture, massage, yoga for cancer pain
The new guideline “takes a deeper dive on the use of integrative therapies, which is important because clinicians and patients need to have access...
Livin' on the MDedge
Meet our newest genetically engineered frenemy, herpes
Plus: Cooking and cleaning your way to air pollution, dying to become a tree, and thawing out “COVID-frozen” goals.
From the Journals
In stage IIIA melanoma, nodal tumor size could guide decision-making
Sentinel node tumors 3 mm or larger should be considered for adjuvant therapy, while smaller sizes could be treated similarly to AJCC IB.
Conference Coverage
Neoadjuvant immunotherapy shows promise for resectable CSCC
Response to treatment may lead to a reduction in potentially disfiguring surgeries.
Conference Coverage
Weight gain linked to cancer survival in men and women
The finding underscores the need for nutritional support emphasized in 2020 ASCO guidelines.